PANEL DATA ANALYSIS SHOWS PERITONEAL DIALYSIS TO BE NEGATIVELY ASSOCIATED WITH HOSPITALIZATION AT THE STATE LEVEL

Author(s)

David R Walker, PhD, Senior Manager, Janeen DuChane, PhD, Director, Samir K Bhattacharyya, PhD, MS, MSc, Senior Director Baxter Health Care, McGaw Park, IL, USA

OBJECTIVES: Hemodialysis (HD) and peritoneal dialysis (PD) are the two main types of dialysis therapy performed on patients with ESRD. The United States Renal Data System (USRDS) produces, among a host of other types of data, annual State-level data related to dialysis and hospitalizations. Panel data sets (cross-sectional time series) can be created from these USRDS data to estimate the impact of dialysis therapy on hospitalization rates at an aggregate level. The objective of this study is to assess the relationship of hospitalizations and dialysis therapies using USRDS State-level data. METHODS: Data used in the analysis were obtained from the 1999 through 2005 Annual Data Reports on the USRDS Web site. The data covers the fifty states plus Washington D.C. for the years 1997 through 2003. Regression analysis was performed on the panel data using the TSCSREG procedure in SAS 9.1. A one-way fixed effects model was used. The dependent variable was the Standardized Hospitalization Ratio (SHR). SHR is the ratio of observed over expected hospitalization events in the ESRD population. The independent variables included in the regression analysis were dialysis modality, demographics, and other State-level data. RESULTS: The adjusted R2 for the estimated regression model was 0.88. The results showed that the percent of dialysis patients on PD was negatively associated with SHR (p <0.01) whereas HD was positively associated with SHR (p <0.01). In addition, an interaction term between the percent of the ESRD population with diabetes and the percent of the State population under 65 years of age was positively associated with SHR (p <0.0001). CONCLUSION: A robust econometrics model on aggregate State-level USRDS data showed PD was negatively associated with hospitalization. Policymakers and payers need to carefully consider the impact of health care policy on dialysis modality choice and thus on costs.

Conference/Value in Health Info

2007-05, ISPOR 2007, Arlington, VA, USA

Value in Health, Vol. 10, No.3 (May/June 2007)

Code

PUK13

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Urinary/Kidney Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×